Stemline Therapeutic (STML)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 43,217 | 500 | 898 | 1,041 | 654 |
| Cost of Goods | 4,893 | N/A | N/A | N/A | N/A |
| Gross Profit | 38,324 | 500 | 898 | 1,041 | 654 |
| Operating Expenses | 118,464 | 86,787 | 69,457 | 39,927 | 38,288 |
| Operating Income | -79,248 | -86,287 | -68,558 | -38,886 | -37,633 |
| Interest Expense | 35 | 1 | 0 | 0 | 0 |
| Other Income | 2,491 | 1,263 | 730 | 557 | 390 |
| Pre-tax Income | -76,792 | -85,024 | -67,828 | -38,328 | -37,244 |
| Income Tax | 26 | N/A | N/A | -25 | N/A |
| Net Income Continuous | -76,817 | -85,024 | -67,828 | -38,303 | -37,244 |
| Net Income | $-76,817 | $-85,024 | $-67,828 | $-38,303 | $-37,244 |
| EPS Basic Total Ops | -1.83 | -2.99 | -2.94 | -2.15 | -2.15 |
| EPS Basic Continuous Ops | -1.83 | -3.00 | -2.94 | -2.15 | -2.15 |
| EPS Diluted Total Ops | -1.83 | -2.99 | -2.94 | -2.15 | -2.15 |
| EPS Diluted Continuous Ops | -1.83 | -3.00 | -2.94 | -2.15 | -2.15 |
| EPS Diluted Before Non-Recurring Items | -1.83 | -2.99 | -2.94 | -2.15 | -2.15 |
| EBITDA(a) | $-80,149 | $-86,327 | $-68,403 | $-38,584 | $-37,203 |